These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23587662)

  • 1. [Use of adalimumab in a patient with Crohn's disease and extensive generalised psoriasis who achieved complete remission of both conditions].
    Piqueras M; Monfort D; Pol MA; Galter S; Modolell I; Ortiz J; Boadas J
    Gastroenterol Hepatol; 2013; 36(6):396-9. PubMed ID: 23587662
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe psoriasis preceding diagnosis of large bowel Crohn's disease for 15 years.
    Triantafillidis JK; Malgarinos G
    J Crohns Colitis; 2013 Mar; 7(2):e80. PubMed ID: 22883442
    [No Abstract]   [Full Text] [Related]  

  • 3. [How I treat....psoriasis comorbidities by adalimumab (Humira) anti-TNFalpha].
    Piérard-Franchimont C; Henry F; Szepetiuk G; Piérard GE
    Rev Med Liege; 2010 Oct; 65(10):545-8. PubMed ID: 21128358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sjögren's syndrome associated with Crohn's disease successfully treated with adalimumab.
    Tursi A
    J Crohns Colitis; 2012 Mar; 6(2):263. PubMed ID: 22325185
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease].
    Rozpondek P; Zwolińska-Wcisło M; Przybylska M; Mach T
    Przegl Lek; 2011; 68(9):602-5. PubMed ID: 22335009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of Adalimumab in Crohn's disease].
    Serghini M; Haddad W; Jeddi H; Karoui S; Ben Mustapha N; Kallel L; Fekih M; Matri S; Boubaker J; Filali A
    Tunis Med; 2012 Feb; 90(2):101-7. PubMed ID: 22407620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case Report of Successful Treatment of Crohn's Disease and Psoriasis With Guselkumab.
    Grossberg LB
    Inflamm Bowel Dis; 2019 Jun; 25(7):e84. PubMed ID: 30863855
    [No Abstract]   [Full Text] [Related]  

  • 8. [The use of adalimumab in severe fistulising Crohn's disease].
    Bang UC; Nielsen AM
    Ugeskr Laeger; 2008 Jun; 170(25):2256. PubMed ID: 18565318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First case report of adalimumab-induced psoriasis in Crohn's disease.
    Harris MD; Richards R
    Am J Gastroenterol; 2009 Mar; 104(3):792-3. PubMed ID: 19262532
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute coronary syndrome in a Crohn's disease patient treated with adalimumab.
    Petitpain N; Bornert-Keller N; Peyrin-Biroulet L
    J Crohns Colitis; 2013 Oct; 7(9):e396. PubMed ID: 23523265
    [No Abstract]   [Full Text] [Related]  

  • 11. Adalimumab for a co-existing clinical condition of Crohn's disease and acrodermatitis continua of Hallopeau.
    Caputo F; Parro S; Zoli G
    J Crohns Colitis; 2011 Dec; 5(6):649. PubMed ID: 22115391
    [No Abstract]   [Full Text] [Related]  

  • 12. Adalimumab for cutaneous metastatic Crohn's disease.
    Cury DB; Moss AC; Elias G; Nakao A
    Inflamm Bowel Dis; 2010 May; 16(5):723-4. PubMed ID: 19728388
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe adalimumab-induced thrombocytopenia in a patient with Crohn's disease.
    Casanova MJ; Chaparro M; Martínez S; Vicuña I; Gisbert JP
    J Crohns Colitis; 2012 Dec; 6(10):1034-7. PubMed ID: 22534313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis].
    Sansó Sureda A; Rocamora Durán V; Sapiña Camaró A; Royo Escosa V; Bosque López MJ
    Gastroenterol Hepatol; 2011 Oct; 34(8):546-50. PubMed ID: 21665330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcoidosis complicating treatment with adalimumab for Crohn's disease.
    McDonnell MJ; Rutherford RM; O'Regan A
    J Crohns Colitis; 2014 Sep; 8(9):1140-1. PubMed ID: 24631310
    [No Abstract]   [Full Text] [Related]  

  • 16. Palmoplantar pustulosis with fulminant dystrophic 20-nail psoriasis in a patient receiving adalimumab therapy.
    Mishra V; Daniel RC; Elmets CA; Levin A; Elewski BE
    J Drugs Dermatol; 2013 Jan; 12(1):16-7. PubMed ID: 23377322
    [No Abstract]   [Full Text] [Related]  

  • 17. Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG; Nieminen U; Sipponen T; Turunen U; Arkkila P; Färkkilä M
    Scand J Gastroenterol; 2013 May; 48(5):543-51. PubMed ID: 23477356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI).
    Dewint P; Hansen BE; Verhey E; Oldenburg B; Hommes DW; Pierik M; Ponsioen CI; van Dullemen HM; Russel M; van Bodegraven AA; van der Woude CJ
    Gut; 2014 Feb; 63(2):292-9. PubMed ID: 23525574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The cost effectiveness of adalimumab in Crohn's disease (review of foreign pharmacoeconomic studies)].
    Rudakova AV
    Eksp Klin Gastroenterol; 2011; (9):113-9. PubMed ID: 22629787
    [No Abstract]   [Full Text] [Related]  

  • 20. Adalimumab reversed a severe lymphopenia in a patient with Crohn's disease.
    Taxonera C; Mendoza JL; Ortega L; Pérez MI; Díaz-Rubio M
    J Crohns Colitis; 2012 May; 6(4):488-91. PubMed ID: 22398051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.